ArticleOncotarget2021

Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma.

Sarah Adriana Scuderi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.